The caudal type homeobox 2 transcription factor (CDX2) is an emerging biomarker in CRC (Dalerba et al., 2016) and is currently used in the clinic for diagnosis of intestinal adenocarcinomas as it is a relatively sensitive and specific intestinal marker. The gene discussed is CDX2; the disease is colorectal carcinoma.